Postoperative infected sebaceous cysts
Conditions
Interventions
Control group:Usual care
Experimental Group B:Conventional treatment + traditional Chinese medicine instead of tea
Experimental Group A:Routine treatment + good irrigation with Chinese medicine
Experimental Group C:Routine treatment and good irrigation with traditional Chinese medicine combined with tea drinking
Sponsors
Shanghai Yangpu Central Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1)Adult patients diagnosed with infectious sebaceous cyst and treated with surgery: the diagnostic criteria refer to the 2005 edition of the new Guidelines for the diagnosis and Treatment of Dermatology . Sebaceous cyst secondary infection protruding from the skin of the tumor will suddenly swell red accompanied by pain touch the surface soft hot with a sense of fluctuation severe rupture of pus there is a foul smell. (2) Surgical standards conforming to fusiform incision resection and (or) incision and drainage: surgical standards refer to the 2012 edition of Practical Dermatological Surgery . 1) Spindle incision resection: bypass the central sebaceous gland opening make a spindle incision along the edge of the cyst and its proximal edge is parallel to the dermatophytes; 2) Incision and drainage: a transverse or curved incision was made along the dermatomal lines below the most obvious fluctuation of the abscess. (3) Postoperative incision diameter ranged from 2cm to 5cm and incision depth =0.5-1.5cm; (4) The level of self-care was taken as the standard of being able to adhere to medical treatment; (5) The age range of the study population was set to 18 to 70 years (6) Voluntary participation and signed informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with serious systemic diseases such as heart brain liver and kidney or malignant tumors; (2)Refuse or tolerate TCM intervention; (3) Women of childbearing age who were preparing for pregnancy or were in the stage of breastfeeding during pregnancy or the trial period; (4) Malignant transformation of the wound; (5) Patients were diagnosed with diabetes or fasting blood glucose =7.0mmol/L.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The wound healing rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adherence TO TREATMENT;Nursing satisfaction;Assessment OF PAIN;Wound recovery;cost-effectiveness ration and incremental cost-effectiveness ration; | — |
Countries
CHINA
Contacts
Public ContactZHU JIE
Shanghai Yangpu Central Hospital
Outcome results
None listed